Relugolix

SL-8817

Relugolix, >98%

CAS No. : [737789-87-6]

Synonyms : TAK-385

IUPAC Name : 1-(4-(1-(2,6-Difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
100MG	155.00		In Stock	Estimated to ship on 20 September 2026
250MG	285.00		In Stock	Estimated to ship on 20 September 2026
1G	555.00		In Stock	Estimated to ship on 20 September 2026
5G	1555.00		In Stock	Estimated to ship on 20 September 2026

Applications : Relugolix is a potent, orally active, nonpeptidic gonadotropin-releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0.33 nM) and monkey receptor (IC50=0.32 nM) compared with TAK-013 (HY-100209). It is used for the study of sex-hormone-dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer.

References : Miwa K. et al.: J. Med. Chem., 54(14), 4998-5012, 2011; Nakata D. et al.: Eur J. Pharmacol., 723, 167-174, 2014.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.